Digital Medicine Society

What Digital Medicine Society does

The Digital Medicine Society (DiMe) is a 501(c)(3) nonprofit professional society founded in 2019 and headquartered in Boston, Massachusetts. It operates as a pre-competitive convening organization that brings together pharmaceutical companies, digital health developers, healthcare providers, payers, regulators, and patient advocates to co-develop open-access standards, frameworks, and toolkits for digital medicine. DiMe does not develop proprietary software or hardware products; its core output is a library of measurement standards, implementation playbooks, and governance resources (including the V3+ Framework, sDHT Adoption Navigator, pediatric rare disease digital measures, mental health digital measures, and the AI Implementation Playbook) that define industry best practices for sensor-based digital health technologies, virtual-first care, and AI in healthcare. The organization's research output includes 40 peer-reviewed publications cited 1,370+ times in academic literature, with the V3 framework alone cited 297 times.

DiMe generates revenue through four primary streams: (1) sponsorships and project participation fees from organizations joining initiatives as title sponsors (Intel, Omada Health) or founding partners (Wheel, Welldoc, Google for Health, BioMarin, Ypsomed, PHIL Inc., Mass General Brigham, Stanford Medicine, Boston Children's Hospital); (2) grants from charitable foundations (Wellcome) and federal agencies (FDA funding for the sDHT Adoption Navigator); (3) fee-based online courses through the Digital Medicine Academy; and (4) DiMe Seal certification fees from digital health platforms evaluated on clinical evidence, privacy/security, and usability. The DiMe Seal was designated by CMS in February 2026 as a required credential for digital health apps seeking inclusion in the Medicare App Library, providing access to 68+ million Medicare beneficiaries. The organization operates with 11-50 employees and runs multiple collaborative communities including DATAcc (digital health measurement), the V1C Coalition (virtual-first care), and the Connected Health Collaborative Community, with active project portfolios spanning more than 10 concurrent initiatives across pediatric rare disease, mental health, AI governance, aging in place, direct-to-patient pharma, and clinical trial digital endpoints.

Name

Digital Medicine Society

Legal name

The Digital Medicine Society, Inc.

Website

https://dimesociety.org

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

The Digital Medicine Society (DiMe) is a Boston-based 501(c)(3) nonprofit that convenes pharma, digital health developers, regulators, and providers to co-develop open-access frameworks, measurement standards, and certifications for digital medicine, with the DiMe Seal designated by CMS for the Medicare App Library.

Ownership category

akta.pro rank

Product category

Digital Health Professional Services

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Health Services (8000)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Digital health standards
• Digital clinical measures
• Healthcare AI governance
• Digital medicine certification
• Clinical trial endpoints

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Digital Medicine Academy (paid courses): DiMe offers fee-based online courses and educational programs for individuals and organizations through its Digital Medicine Academy. Courses include Applied Digital Health Ethics, Building Fit-for-Purpose Sensor-based DHTs, Capturing the Value of V1C, Google's Generative AI for Healthcare, Health AI for Low-Resource Healthcare Settings, and Fast Track to Digital Clinical Trials (Pharma Edition). Revenue is generated through course enrollment fees paid by individuals and organizational bulk licenses.
2. Sponsorships and project participation fees: Organizations pay to sponsor DiMe initiatives and projects, gaining visibility and early access to pre-competitive frameworks. Title sponsors (e.g., Omada Health, Intel) and founding partners (e.g., Wheel, Welldoc) contribute financially to specific initiatives. Sponsorship tiers include title sponsor and founding partner roles.
3. DiMe Seal certification fees: Digital health platforms pay to be evaluated and certified under the DiMe Seal program. The seal indicates platforms meet standards for clinical evidence, privacy, security, and usability. CMS has designated the DiMe Seal as a required credential for Medicare App Library inclusion, creating demand for this certification service.
4. Free open-access resources: DiMe publishes hundreds of free resources including playbooks, toolkits, glossaries, and measurement frameworks. This open-access model builds community and positions DiMe as the preeminent authority in digital medicine, indirectly driving paid offerings.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Digital Medicine Society (DiMe) is a 501(c)(3) nonprofit professional society that develops open-access frameworks, toolkits, digital clinical measurement standards, and governance resources for the digital medicine field. It operates the Digital Medicine Academy for paid individual and organizational courses and the DiMe Seal certification program for digital health platforms. DiMe convenes multi-stakeholder coalitions across pharma, digital health developers, payers, providers, and regulators through project sprints, collaborative communities (DATAcc, Connected Health Collaborative, V1C Coalition), and conferences.

Differentiator

Problem solved

Functional benefit

Brands

• DATAcc by DiMe: Digital Health Measurement Collaborative Community - focuses on digital health measurement best practices and sensor-based digital health technologies
• V1C Coalition by DiMe
• Connected Health Collaborative Community (CHcc)
• Digital Medicine Academy
• DiMe Seal
• sDHT Adoption Navigator
• NaVi

Products and services

• Digital Medicine Academy

Quantifiable outcome

• Reduce phase II pediatric rare disease clinical trial timelines by approximately 3 months
• +3 more outcomes

Named customers5 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Partnerships

22 partnerships are on record, tiered flagship, core and minor.

• Omada HealthflagshipStrategic or Co-development Partner · 9 June 2026Omada Health joined DiMe's Post-Contracting Operational Readiness for Virtual-First Care project as title sponsor. The initiative develops shared operational best practices for integrating contracted virtual care providers into payer systems within 90 days of contract signature. Omada's sponsorship supports the 3.5-month sprint and toolkit development addressing virtual care provider operational gaps.
• FDAflagshipStrategic or Co-development Partner · 4 June 2026The FDA is a collaborator in DATAcc by DiMe's digital measures for common mental health disorders, alongside pharmaceutical companies, digital health platforms, research institutions, and advocacy groups. FDA's involvement signals regulatory endorsement of the digital measurement framework.
• CARIN AlliancecoreStrategic or Co-development Partner · 1 May 2026The CARIN Alliance collaborates with DiMe and CMS to develop criteria for which healthcare apps meet security and trustworthiness standards for inclusion in the Medicare app library, helping apps get into the Medicare ecosystem.
• WheelcoreStrategic or Co-development Partner · 16 April 2026Wheel, a virtual care infrastructure company, joined DiMe's 'Optimizing Direct-to-Patient (DTP) Strategies for Pharma' initiative as a founding partner. The initiative develops operational, regulatory, and evidence-based foundations for scaling direct-to-patient healthcare models.
• WelldoccoreStrategic or Co-development Partner · 16 April 2026Welldoc joined DiMe's DTP Strategies for Pharma initiative as a founding partner, contributing to the development of a practical blueprint ensuring DTP models operate safely and earn patient trust.
• PHIL Inc.coreStrategic or Co-development Partner · 16 April 2026PHIL Inc. joined DiMe's DTP Strategies for Pharma initiative as a founding partner, collaborating with other digital health and pharma companies to co-create standards for direct-to-patient models.
• YpsomedcoreStrategic or Co-development Partner · 16 April 2026Ypsomed, a pharmaceutical delivery systems company, joined DiMe's DTP Strategies for Pharma initiative as a founding partner, contributing to the cross-sector coalition developing standards for direct-to-consumer pharmaceutical models.
• American Osteopathic Information Association (AOiA)minorStrategic or Co-development Partner · 10 March 2026AOiA promoted CMS's adoption of digital health standards through its partnership with DiMe (DiMe Seal), highlighting DiMe's role in promoting trust and safety in digital health tools for Medicare beneficiaries.
• Centers for Medicare & Medicaid Services (CMS)flagshipStrategic or Co-development Partner · 24 February 2026CMS designated the DiMe Seal as a required credential for digital health applications seeking inclusion in the Medicare App Library, the first government mandate of its kind for a digital health certification. The library launch is anticipated before July 4, 2026, serving 68+ million beneficiaries.
• FDAflagshipStrategic or Co-development Partner · 4 February 2026The FDA funded the development of DiMe's sDHT Adoption Navigator, an interactive online resource that organizes regulatory guidance, standards, and industry practices for integrating sensor-based digital health technologies into clinical trials. The FDA's funding and involvement validates the tool's regulatory relevance.
• FDAflagshipStrategic or Co-development Partner · 2 February 2026The FDA collaborated with DiMe on the pediatric rare disease digital clinical measures project, working alongside pharmaceutical companies, children's hospitals, patient advocacy organizations, and regulatory bodies to standardize how treatment outcomes are captured across rare pediatric conditions.
• BioMarincoreStrategic or Co-development Partner · 29 January 2026BioMarin collaborated with DiMe, FDA, Northwestern Medicine, and Stanford Medicine on the first core set of digital clinical measures for pediatric rare diseases, contributing pharma development expertise to the open-access toolkit.
• Northwestern MedicinecoreStrategic or Co-development Partner · 29 January 2026Northwestern Medicine collaborated with DiMe on pediatric rare disease digital clinical measures, providing clinical research expertise and hospital-based perspective on rare pediatric conditions.
• Stanford MedicinecoreStrategic or Co-development Partner · 29 January 2026Stanford Medicine collaborated with DiMe on the pediatric rare disease digital measures set, contributing to the open-access toolkit designed to accelerate rare disease treatment development.
• Intel (Title Sponsor)flagshipStrategic or Co-development Partner · 9 January 2026Intel serves as the Title Sponsor of DiMe's 'Scaling Trusted, High-Impact AI Care Navigation' initiative, which brings together over 15 founding members including tech companies, hospital systems, and patient advocacy groups to develop evidence-based standards and frameworks for AI-enabled patient care navigation.
• Google for HealthcoreStrategic or Co-development Partner · 9 January 2026Google for Health is a founding member of DiMe's AI Care Navigation initiative. The collaboration builds on prior DiMe work with Google for Health and aligns with CMS and ONC policy guidance as AI becomes embedded in healthcare delivery.
• Boston Children's HospitalcoreStrategic or Co-development Partner · 9 January 2026Boston Children's Hospital is a founding member of DiMe's AI Care Navigation initiative, contributing clinical expertise to develop open-access resources ensuring AI-enabled care journeys are patient-centered and equitable.
• Mass General BrighamcoreStrategic or Co-development Partner · 9 January 2026Mass General Brigham is a founding member of DiMe's AI Care Navigation initiative, collaborating with other hospital systems and tech partners to develop evidence-based frameworks for AI in patient care navigation.
• Stanford MedicinecoreStrategic or Co-development Partner · 9 January 2026Stanford Medicine is a founding member of DiMe's AI Care Navigation initiative, contributing research and clinical expertise to standards development for AI-enabled care management.
• National Health CouncilcoreStrategic or Co-development Partner · 9 January 2026The National Health Council, representing patients and caregivers, is a founding member of the AI Care Navigation initiative, ensuring patient-centeredness and equity in the development of AI governance frameworks.
• SimpleCminorStrategic or Co-development Partner · 9 January 2026SimpleC announced a 2026 partnership with DiMe to create an ecosystem for 125 million older adults and their care partners. SimpleC launched Wellby, an AI-powered caregiver companion, at CES in partnership with DiMe's Connected Health Collaborative.
• Consumer Technology AssociationcoreStrategic or Co-development Partner · 7 November 2025The Consumer Technology Association collaborates with DiMe and over 20 industry partners on the Connected Health Collaborative's initiative to create a digital blueprint for tech-enabled aging in place for seniors in the US.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• HIMSS (Healthcare Information and Management Systems Society): The largest healthcare IT professional society globally, HIMSS runs major conferences, develops industry standards, and offers educational programs. DiMe is comparable as a non-profit professional society convening stakeholders around digital health, though HIMSS is significantly larger and broader in scope.
• HL7 International (Health Level Seven): A global non-profit standards body developing interoperability frameworks (e.g., FHIR) for healthcare data exchange. HL7 is comparable to DiMe as a healthcare standards-setting organization, though it is more established and focused specifically on data interoperability.

Direct peers

• AMIA (American Medical Informatics Association): A non-profit professional association for informatics in healthcare, AMIA develops standards, runs educational programs, and convenes researchers and practitioners. AMIA is directly comparable to DiMe in mission and operating model, with a narrower focus on clinical informatics.
• Digital Therapeutics Alliance (DTA): An industry trade association advancing digital therapeutics, DTA convenes stakeholders, develops policy frameworks, and advocates for DTx adoption. DTA is directly comparable to DiMe in its pre-competitive convening and standards-development role, with a narrower focus on prescription digital therapeutics.
• American Telemedicine Association (ATA): A non-profit association focused on telehealth policy, standards, and education, ATA convenes stakeholders and advocates for virtual care adoption. ATA is directly comparable to DiMe's V1C Coalition work and shares the non-profit professional society model.
• PCHAlliance (Personal Connected Health Alliance): A non-profit organization focused on advancing personal connected health and wearables, PCHAlliance convenes industry and develops frameworks. PCHAlliance is comparable to DiMe's Connected Health Collaborative Community work on sensor-based and connected health technologies.
• Xcertia: A multi-stakeholder coalition developing guidelines for mobile health applications, with a focus on privacy, security, and content standards. Xcertia is directly comparable to DiMe's Seal program as a digital health app certification initiative, though it has narrower adoption and no CMS designation.

Emerging players

• HLTH Foundation: The non-profit arm of the HLTH conference, focused on health innovation and equity. HLTH Foundation is comparable to DiMe in convening health innovation stakeholders but is younger and primarily operates through the HLTH conference platform.
• Center for Connected Health Policy (CCHP): A non-profit policy organization focused on telehealth and connected health policy at the state and federal level. CCHP is comparable to DiMe's policy and standards work, but with a narrower focus on telehealth policy and reimbursement.

Others

• CARIN Alliance: A multi-stakeholder alliance advancing consumer-directed exchange of health information. CARIN is comparable to DiMe as a digital health ecosystem convenor and is already a DiMe partner on the CMS Medicare App Library criteria. It is an adjacent peer rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digital Medicine Society